What are its advantages?

[Mst.Rina1R]

The National Biotechnology and Medical Industry Policy Association (hereinafter referred to as the Biotechnology Association) held the "2024 Biotechnology Annual Meeting" today, inviting representatives from major technology companies such as Quanta Chairman Lin Baili, Asustek Chairman Shi Chongtang, and Gigabyte Chairman Ye Peicheng to attend , discussing the development of the biomedical industry from the perspective of cross-industry investment.

Weng Qihui, President of the Health Policy Association (4th left iceland telegram in the first picture) pointed out: "Due to the aging of the population, global medical expenditures are growing at 5% every year, and are expected to increase to about 15 trillion US dollars in 2030, accounting for 12% of global GDP. Among them, early Expenditures on detection and prevention are growing the fastest and will reach about US$4 trillion. This shows that the biomedical industry has expanded from traditional disease treatment to precision health (precision health) in preventive diagnosis . In order to increase efficiency and accuracy, ICT is used. and related high-tech companies will play a key role. This is Taiwan’s opportunity.”

Lin Baili (3rd from the left in the first picture) emphasized that the new wave of generative AI technology will bring innovation to the medical field: "I believe that through the play and cooperation of academia, medical care, and the IT industry, we can use the power of AI to Power to solve real health and medical problems and create a healthier, fairer, and smarter future for all.